Alvogen and Reddy’s Cleared Over US Rivals To Suboxone

 
• By Aidan Fry

Alvogen and Dr Reddy’s do not infringe key patents protecting Indivior’s Suboxone Film, the US Court of Appeals has confirmed. But Teva continues to fall foul of a production patent running until 2024.

Suboxone
Generic rivals to Idivior's Suboxone Film from Alvogen and Dr Reddy's can remain on the US market, the Federal Circuit has confirmed • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin